SEC Tracker
Get the app

Exascale Labs Holdings XLAB

Exascale Labs Holdings FY 2026: revenue $14.8M; diluted EPS −$8,108.26

Form
10-K
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Exascale Labs Holdings reported for the year ended Jun 30, 2026, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$14.8MNo year-earlier figure tagged10-K income statement, on EDGAR
  2. Net income−$12.2MNo year-earlier figure tagged10-K income statement, on EDGAR
  3. Diluted EPS−$8,108.26No year-earlier figure tagged10-K income statement, on EDGAR
  4. Cash and cash equivalents$2.7MNo year-earlier figure tagged10-K balance sheet, on EDGAR
  5. Cash from operations−$2.8MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Exascale Labs Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 7372 and related industry codes: the same peer list as the financial tables.

  1. Cardlytics CDLX public float $86M, Jun 30, 2025
  2. CareCloud CCLD public float $85M, Jun 30, 2025
  3. Liveperson LPSN public float $85M, Jun 30, 2025
  4. WM Technology MAPS public float $85M, Jun 30, 2025
  5. VPR Brands VPRB public float $92M, Jun 30, 2025